Femoral Nerve Block vs Peri-capsular Nerve Group Block for Hip Fracture Analgesia

Analgesia Clinical Trial

Official title:

Comparison of Femoral Nerve Block Versus Peri-capsular Nerve Group Block for Analgesia During Positioning for Spinal Anesthesia in Patients With Hip Fracture

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05444803
• Other study ID #: safa1
• Status: Completed
• Phase: N/A
• Start date: July 6, 2022
• Est. completion date: December 19, 2022

Study information

• Verified date: June 2022
• Source: Antalya Training and Research Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of the study is to compare the analgesic efficacy of femoral nerve block and peri-capsular nerve group block administered before spinal anesthesia for positioning to spinal anaesthesia in patients undergoing surgery for hip fracture and to evaluate the efficacy for postoperative analgesia

Description:

Spinal anesthesia is commonly used in patients undergoing hip fracture surgery. However the procedure of patient positioning to perform a spinal block is painful and may require the administration of IV analgesics or some regional anesthesia techniques such as femoral nerve block, fascia-iliaca compartment block, peri-capsular nerve group block. At the study, the investigators aimed to compare analgesic efficacy of femoral nerve block and peri-capsular nerve group block administered before spinal anesthesia for positioning to spinal anaesthesia in patients undergoing surgery for hip fracture and to evaluate the efficacy for postoperative analgesia.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 52
• Est. completion date: December 19, 2022
• Est. primary completion date: November 7, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 85 Years

Eligibility

Inclusion Criteria:

• patients with hip fracture scheduled for surgery under spinal anesthesia.

Exclusion Criteria:

• hemorrhagic diathesis,
• peripheral neuropathy,
• allergy to local anesthetics,
• mental disorders,
• use of analgesics for 8 h before the performance of spinal block

Related Conditions & MeSH terms

• Analgesia
• Fractures, Bone
• Hip Fractures
• Spinal Anesthesia

Intervention

Other:
• femoral nerve block
Patients will be performed a femoral nerve block using bupivacaine thirty minutes before the performing of spinal block.
• peri-capsular nerve group block
Patients will be performed a peri-capsular nerve group block using bupivacaine thirty minutes before the performing of spinal block.

Locations

Country	Name	City	State
Turkey	Antalya Training and Research Hospital	Antalya

Sponsors (1)

Lead Sponsor	Collaborator
Antalya Training and Research Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Rate of pain scores assessed by Numerical rating Score Scale during positioning for spinal anesthesia	Pain scores will be assessed by Numerical Rating Scale (NRS) scores (from 0=no pain to 10=maximum possible pain).	30 minutes
Secondary	Rate of pain scores at rest	Pain scores will be assessed by Numerical Rating Scale (NRS) scores from 0 (no pain) to 10 (maximum possible pain) at rest before and 30 min after the block performance.	30 min
Secondary	Rate of pain scores on passive limb lifting	Pain scores will be assessed by Numerical Rating Scale (NRS) scores from 0 (no pain) to 10 (maximum possible pain) on passive limb lifting before and 30 min after the block performance.	30 min
Secondary	rate of postoperative pain scores	Pain scores will be assessed by Numerical Rating Scale (NRS) scores from 0 (no pain) to 10 (maximum possible pain).at 6, 12, 24 hours postoperatively.	24 hours
Secondary	Amount of postoperative analgesic consumption	Postoperative analgesic consumption will be recorded for postoperative 24 hours	24 hours